简介：Thesolidaddofthefirstprotonatedzincoborophosphate,(H3O)Zn(H2O)2BP2O8·H2O(1),wassoventothermallysyn-thesizedbythereactionofZn(NO3)2·6H2OandH3BO3withH3PO4inamixedsolvent,andstructurallycharacterizedbysingle-ystalX-raydiffractionanalysis.ItcrystallizesinthehexagonalP6122,a=0.9604(4)nm,c=1.5297(6)nm,V=1.2218(8)nm^3,Dc=2.921g/cm^3,Z=6,F(000)=1080,μ=3.495mm^-1.Thestmchwefeaturesthatthetetrahedra-te-trahedrahdlcesinterconnectedbyoctahedraandstronghydro-gembondinteractionsformathree-dimensionalframework.Theprotonatedwatermoleculesarelocatedatuniquepositions.othercharacterizationsbyIRandthermalanalysisarealsode-scribed.
简介：对化合物[Na_2（H_2O）_（10）][Cu_4（H_2O）_（12）（H_2W_（12）O_（42））]·15H_2O（简称Na_2Cu_4W_（12））进行了体外抗肿瘤活性研究.应用四甲基偶氮唑盐（3-[4,5-dimethylthiazo-2-y]-2,5-diphenyltetrazoliumbromide,MTT）比色法分析Na_2Cu_4W_（12）对人肝癌细胞（HepG2）、人神经母细胞瘤细胞（SHY5Y）增殖抑制活性.采用光学显微镜观察肿瘤细胞的凋亡形态变化,用流式细胞术分析细胞周期和细胞凋亡,计算各期细胞比例及细胞凋亡率.结果表明,Na_2Cu_4W_（12）对HepG2和SHY5Y2种肿瘤细胞增殖半数抑制浓度IC_（50）值分别为5.3和10.2μmol·L~（-1）,且呈剂量依赖性.光学显微镜下处理组细胞出现皱缩、变圆、缩小等形态变化,不同浓度Na_2Cu_4W_（12）处理12h早期凋亡细胞所占的百分比显著增加且呈剂量依赖性.综上所述,Na_2Cu_4W_（12）能够抑制胞瘤细胞增殖,诱导细胞凋亡.
简介：AsimplespectrophotometricassayofH2O2andglucoseusingAgnanoparticleshasbeencarriedout.RelyingonthesynergisticeffectofH2O2reductionandultraviolet(UV)irradiation,Agnanoparticleswithenhancedabsorptionsignalsweresynthesized.H2O2servedasareducingagentintheAgnanoparticlesformationinwhichAg+wasreducedtoAg0byO2àgeneratedviathedecompositionofH2O2inalkalinemedia.Ontheotherhand,photoreductionofAg+toAg0underUVirradiationsalsocontributedtothenanoparticlesformation.ThesynthesizednanoparticleswerecharacterizedbyTEM,XPS,andXRD.TheproposedmethodcoulddetermineH2O2withconcentrationsrangingfrom5.010à7to6.010à5mol/L.Thedetectionlimitwasestimatedtobe2.010à7mol/L.SincetheconversionofglucosetogluconicacidcatalyzedbyglucoseoxidasewascompaniedwiththeformationofH2O2,thesensingprotocolhasbeensuccessfullyutilizedforthedeterminationofglucoseinhumanbloodsamples.Theresultswereingoodagreementwiththosedeterminedbyalocalhospital.Thiscolorimetricsensorthusholdsgreatpromisesinclinicalapplications.
简介：Yb3+complexeswithtwonitrilotriaceticacidmoleculeswerepreparedandtheircompositionsweredeterminedasK3[Yb(nta)2(H2O)]*5H2OandNa3[Yb(nta)2]*6H2Obyelementalanalyses.Theirstructureswerecharacterizedbysingle-crystalX-raydiffractionanalyses.IncomplexK3[Yb(nta)2(H2O)]*5H2O,theYbN2O7partformsanine-coordinatemonocappedsquareantiprismaticstructure.IncomplexNa3[Yb(nta)2]*6H2O,theYbN2O6partformsaneight-coordinatesquareantiprismaticstructure.Itcanbeseenthattheoutercations(K+andNa+)greatlyaffectthecoordinationnumberandcoordinatestructurefromtheseresults.
简介：TheantibacterialeffectofcarryingsilverB2O3-SiO2-Na2Oglassmaterialwasstudiedbymeansofantibacterialring,nephelometery,MICvalue,thinfilmattachmentandmicrocalorimetry,respectively.TheexperimentalresultsoffivekindsofantibacterialtestmethodsarealmostidenticalandcanverifythatcarryingsilverB2O3-SiO2-Na2Oglassmaterialexertsanexcellentantibacterialperformance.Antibacterialringandnephelometeryaresimple,quick,buttheprecisionisrestrictive.MICvalue,thinfilmattachmentmethodandmicrocalorimetrycanquantitativelycomparetheantibacterialeffectsoftheantibacterialglassmaterial.Comparedwiththetraditionalmicrobetestmethods,themicrocalorimetrycananalyzetheinhibitingeffectofthecell'sgrowthandmetabolismontheantibacterialglassmaterialbymonitoringthethermaleffectcontinuouslyandautomatically.
简介：Twooxo-vanadium(IV)complexes,[VO(C2O4)(2,2′-bipy)(H2O)]·C2H5OH(1)andVO(C2O4)(phen)(H2O)(2),where2,2′-bipy=2,2′-bipyridyl,phen=1,10-phenanthroline,weresynthesizedaspotentialfunctionalmodelsofvanadiumhaloperoxidases(VHPOs)inmixedsolventofethanolandwateratroomtemperature.Thecomplexeswerecharacterizedbyelementalanalysis,infrared(IR),UV-VisandX-raycrystallography.Structuralanalysesshowedthatvanadiumatomwascoordinatedbyaterminaloxygen,oneoxygenatomfromcoordinatedwater,twooxygenatomsfromthecarboxylategroupofoxalicacid,andtwonitrogenatoms(N1andN2)from2,2′-bipy/phen.Centralvanadiumatomsincomplexes1and2werebothinadistorted-octahedralenvironment,andsomeintermolecularhydrogenbondinglinkageswerealsoobservedineachcomplex.BrominationreactionactivityofthetwocomplexeswasevaluatedwithphenolredasorganicsubstrateinthepresenceofH2O2,Br-andphosphatebuffer,indicatingthattheycanbeconsideredasapotentialfunctionalmodelofVHPO.Inaddition,thermalanalysiswasalsoperformedanddiscussedindetail.
简介：本文报道了Ｃ６Ｈ１２Ｏ６（ＮＨ４）２ＳＯ４Ｃ２Ｈ５ＯＨＨ２Ｏ（Ｃ２Ｈ５ＯＨ／Ｈ２Ｏ＝０．９０）体系在３５℃时体系溶解度和饱和溶液的折光指数，并绘出了体系相应的溶度图和饱和溶液的折光指数曲线图。结果表明：所研究的体系为四元体系Ｃ６Ｈ１２Ｏ６（ＮＨ４）２ＳＯ４Ｃ２Ｈ５ＯＨＨ２Ｏ中的一部分。当溶液中肌醇饱和时，溶度曲线落在约５０％的等醇水比面上。当（ＮＨ４）２ＳＯ４在溶液中达到饱和时，出现共饱点。其组成为（ＮＨ４）２ＳＯ４：２１０％，Ｃ６Ｈ１２Ｏ６：２．０８％，Ｃ２Ｈ５ＯＨ：４４７５％。同时出现分层，在富醇相随着乙醇浓度的增加，出现肌醇与硫酸铵共饱线。在富水相硫酸铵饱和溶度曲线落在约５％乙醇的等醇水比面上，折光指数曲线由三支组成，其中两条分别与Ｃ６Ｈ１２Ｏ６·Ｈ２Ｏ和（ＮＨ４）２ＳＯ４相对应，另外一条线与（ＮＨ４）２ＳＯ４和Ｃ６Ｈ１２Ｏ６·Ｈ２Ｏ的共饱线相对应
客服QQ：30444492琼网文【2021】1550-113号
增值电信业务经营许可证：琼B2-20210322
出版物经营许可证：新出发龙华出字第(2021)009号
广播电视节目制作经营许可证：(琼)字第00779号
版权所有 ©2002-2024 期刊网(www.qikanchina.com) 琼ICP备2021005105号
![新型仲钨酸盐-B化合物[<b style='color:red'>Na</b>_<b style='color:red'>2</b>（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）_（10）][Cu_4（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）_（12）（<b style='color:red'>H</b>_<b style='color:red'>2</b>W_（12）<b style='color:red'>O</b>_（42））]·15<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>体外抗肿瘤活性研究](/image/thesis5 "新型仲钨酸盐-B化合物[<b style='color:red'>Na</b>_<b style='color:red'>2</b>（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）_（10）][Cu_4（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）_（12）（<b style='color:red'>H</b>_<b style='color:red'>2</b>W_（12）<b style='color:red'>O</b>_（42））]·15<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>体外抗肿瘤活性研究")
![Crystal Structure and Bioactivity of Complex [Gd（C10<b style='color:red'>H</b>9N<b style='color:red'>2</b><b style='color:red'>O</b>4）（C10<b style='color:red'>H</b>8N<b style='color:red'>2</b><b style='color:red'>O</b>4）（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）3]<b style='color:red'>2</b>·phen·4<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>](/image/thesis6 "Crystal Structure and Bioactivity of Complex [Gd（C10<b style='color:red'>H</b>9N<b style='color:red'>2</b><b style='color:red'>O</b>4）（C10<b style='color:red'>H</b>8N<b style='color:red'>2</b><b style='color:red'>O</b>4）（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）3]<b style='color:red'>2</b>·phen·4<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>")
![Syntheses, Crystal Structures and Characterization of Two Zeotype Crystals of K4[Cr30（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>） 3（OOCH） 6] <b style='color:red'>2</b>[ P<b style='color:red'>2</b>W18<b style='color:red'>O</b>62]· 9.5<b style='color:red'>H</b><b style='color:red'>2</b> <b style='color:red'>O</b> and K4[ Cr3<b style='color:red'>O</b>（ <b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）3（ OOCH）6 ]<b style='color:red'>2</b>[ <b style='color:red'>H</b>3 P<b style='color:red'>2</b> W17Co（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>） <b style='color:red'>O</b>61]· 20<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>](/image/thesis7 "Syntheses, Crystal Structures and Characterization of Two Zeotype Crystals of K4[Cr30（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>） 3（OOCH） 6] <b style='color:red'>2</b>[ P<b style='color:red'>2</b>W18<b style='color:red'>O</b>62]· 9.5<b style='color:red'>H</b><b style='color:red'>2</b> <b style='color:red'>O</b> and K4[ Cr3<b style='color:red'>O</b>（ <b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）3（ OOCH）6 ]<b style='color:red'>2</b>[ <b style='color:red'>H</b>3 P<b style='color:red'>2</b> W17Co（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>） <b style='color:red'>O</b>61]· 20<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>")
![Syntheses and Structural Researches of Yb^3＋ Complexes with Nitrilotriacetic Acids—Nine—coordinate K3[Yb（nta）<b style='color:red'>2</b>（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）]·5<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b> and Eight—coordinate <b style='color:red'>Na</b>3[Yb（nta）<b style='color:red'>2</b>]·6<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b> complexes](/image/thesis9 "Syntheses and Structural Researches of Yb^3＋ Complexes with Nitrilotriacetic Acids—Nine—coordinate K3[Yb（nta）<b style='color:red'>2</b>（<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b>）]·5<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b> and Eight—coordinate <b style='color:red'>Na</b>3[Yb（nta）<b style='color:red'>2</b>]·6<b style='color:red'>H</b><b style='color:red'>2</b><b style='color:red'>O</b> complexes")
![Imidazole Coordinated Sandwich-type Antimony Polyoxotungstates <b style='color:red'>Na</b>9[ {<b style='color:red'>Na</b>（<b style='color:red'>H</b>=<b style='color:red'>O</b><b style='color:red'>2</b>}3{M（C3<b style='color:red'>H</b>4N<b style='color:red'>2</b>）}3（ Sb W9<b style='color:red'>O</b>33）<b style='color:red'>2</b>]·xH=<b style='color:red'>O</b>（M=Ni^Ⅱ, Co^Ⅱ, Zn^Ⅱ, Mn^Ⅱ）](/image/thesis11 "Imidazole Coordinated Sandwich-type Antimony Polyoxotungstates <b style='color:red'>Na</b>9[ {<b style='color:red'>Na</b>（<b style='color:red'>H</b>=<b style='color:red'>O</b><b style='color:red'>2</b>}3{M（C3<b style='color:red'>H</b>4N<b style='color:red'>2</b>）}3（ Sb W9<b style='color:red'>O</b>33）<b style='color:red'>2</b>]·xH=<b style='color:red'>O</b>（M=Ni^Ⅱ, Co^Ⅱ, Zn^Ⅱ, Mn^Ⅱ）")
![Vanadium Haloperoxidases Model Compounds： Synthesis, Structural Characterization and Mimic Catalytic Bromination Activity of [VO（C_<b style='color:red'>2</b><b style='color:red'>O</b>_4）（<b style='color:red'>2</b>,<b style='color:red'>2</b>′-bipy）（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）]·C_<b style='color:red'>2</b><b style='color:red'>H</b>_5OH and VO（C_<b style='color:red'>2</b><b style='color:red'>O</b>_4）（phen）（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）](/image/thesis12 "Vanadium Haloperoxidases Model Compounds： Synthesis, Structural Characterization and Mimic Catalytic Bromination Activity of [VO（C_<b style='color:red'>2</b><b style='color:red'>O</b>_4）（<b style='color:red'>2</b>,<b style='color:red'>2</b>′-bipy）（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）]·C_<b style='color:red'>2</b><b style='color:red'>H</b>_5OH and VO（C_<b style='color:red'>2</b><b style='color:red'>O</b>_4）（phen）（<b style='color:red'>H</b>_<b style='color:red'>2</b><b style='color:red'>O</b>）")
